Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Sector Analysis

Surgical & Medical Instruments & Apparatus

Standard Industrial Classification: SIC 3841

Industry Insider Sentiment Analysis

The Surgical & Medical Instruments & Apparatus sector (SIC 3841) acts as a critical barometer for broader economic health. Our real-time monitoring reveals total transactions. Monitoring "cluster buying" is one of the most reliable leading indicators for future sector performance. By analyzing aggregate data across this specific Standard Industrial Classification, investors can filter out individual company volatility and identify high-conviction trends. When multiple directors and officers within the same industry move capital simultaneously, it often signals an upcoming sector-wide revaluation or a fundamental shift in supply chain dynamics that has yet to be recognized by the broader public market.

Filing Date Trade Date Ticker Company Reporting Person Relationship Type Price Qty Total, $ Owned After
2013-12-20 19:16 2013-12-20 SYK STRYKER CORP STRYKER RONDA E Director SELL $74.09 7,000 $518,657 11,301,682
2013-12-21 04:19 2013-12-18 GMED GLOBUS MEDICAL INC Demski David M Director, Officer SELL $19.75 50,000 $987,500 481,365
2013-12-20 19:03 2013-12-18 ECIA ENCISION INC NAUMANN-ETIENNE RUEDIGER Director BUY $0.80 6,000 $4,800 49,500
2013-12-20 01:08 2013-12-17 ECIA-PK ENCISION INC NEWTON DAVID W Director, Officer BUY $0.80 12,500 $10,000 12,500
2013-12-19 23:46 2013-12-18 SYK STRYKER CORP STRYKER RONDA E Director SELL $72.65 14,000 $1,017,075 11,308,682
2013-12-20 00:28 2013-11-15 LMAT LEMAITRE VASCULAR INC Gebauer Peter R Officer SELL $8.45 5,000 $42,250 7,167
2013-12-20 00:54 2013-12-18 DXCM DEXCOM INC ROPER JESS Officer OPT+S $34.48 8,000 $275,804 65,808
2013-12-19 23:27 2013-12-17 ECIA-PK ENCISION INC CMED PARTNERS LLLP 10% owner BUY $0.80 525,000 $420,000 2,158,517
2013-12-19 23:56 2013-12-17 ECIA-PK ENCISION INC KORNELSEN VERN D Director, 10% owner BUY $0.80 525,000 $420,000 2,158,517
2013-12-19 02:33 2013-12-18 ICUI ICU MEDICAL INC/DE SHERMAN RICHARD MD Director SELL $65.00 3,750 $243,765 67,273
2013-12-17 19:00 2013-12-13 SYK STRYKER CORP STRYKER RONDA E Director SELL $71.54 21,000 $1,502,241 11,322,682
2013-12-17 21:25 2013-12-16 HAE HAEMONETICS CORP HANLON SUSAN M Officer OPT+S $43.50 4,000 $173,982 16,905
2013-12-17 19:16 2013-12-16 BDX BECTON DICKINSON & CO Sichak Stephen Officer SELL $105.82 344 $36,402 7,343
2013-12-17 02:55 2013-12-03 ECIA ENCISION INC PACE PATRICK W Director, Officer BUY $0.80 2,000 $1,600 80,347
2013-12-13 16:54 2013-12-11 BONE Xtant Medical Holdings, Inc. COOK GUY S 10% owner SELL $0.42 160,000 $67,536 4,937,729
2013-12-14 02:56 2013-11-11 LMAT LEMAITRE VASCULAR INC LeMaitre Cornelia W Director, Officer SELL $8.08 35,000 $282,916 433,937
2013-12-14 02:53 2013-10-30 LMAT LEMAITRE VASCULAR INC LeMaitre Cornelia W Director, Officer SELL $7.88 20,000 $157,500 174,581
2013-12-14 04:41 2013-12-11 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer OPT+S $34.41 50,000 $1,720,265 212,813
2013-12-14 01:54 2013-12-12 DXCM DEXCOM INC AUGUSTINOS NICHOLAS Director SELL $34.40 11,321 $389,494 11,130
2013-12-13 00:49 2013-12-11 SYK STRYKER CORP STRYKER RONDA E Director SELL $74.04 14,000 $1,036,547 11,343,682
2013-12-12 04:14 2013-12-09 DXCM DEXCOM INC AUGUSTINOS NICHOLAS Director OPT+S $33.64 97,541 $3,280,811 22,451
2013-12-12 01:10 2013-12-11 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, 10% owner SELL $64.27 25,000 $1,606,680 446,808
2013-12-10 22:59 2013-12-09 SYK STRYKER CORP STRYKER RONDA E Director SELL $74.48 14,000 $1,042,768 11,357,682
2013-12-10 20:45 2013-12-06 UFPT UFP TECHNOLOGIES INC SHAW DANIEL J Officer SELL $25.00 2,473 $61,825 44,480
2013-12-11 01:27 2013-12-06 GMED GLOBUS MEDICAL INC LIPTAK ROBERT Director SELL $19.36 25,000 $484,000 26,159
2013-12-11 01:26 2013-12-09 HAE HAEMONETICS CORP HANLON SUSAN M Officer OPT+S $43.07 3,138 $135,165 16,905
2013-12-10 19:16 2013-12-06 UTMD UTAH MEDICAL PRODUCTS INC CORNWELL KEVIN L Director, Officer SELL $51.65 1,885 $97,367 270,308
2013-12-11 01:26 2013-12-10 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, 10% owner SELL $65.36 17,100 $1,117,627 446,808
2013-12-10 02:13 2013-12-09 ICUI ICU MEDICAL INC/DE LOPEZ GEORGE A Director, 10% owner SELL $65.95 7,900 $520,969 446,808
2013-12-10 02:14 2013-12-09 ICUI ICU MEDICAL INC/DE SHERMAN RICHARD MD Director SELL $65.42 1,550 $101,400 67,273
2013-12-06 20:46 2013-12-04 SYK STRYKER CORP STRYKER RONDA E Director SELL $73.77 21,000 $1,549,115 11,371,682
2013-12-06 20:39 2013-12-04 UFPT UFP TECHNOLOGIES INC SHAW DANIEL J Officer SELL $25.34 7,969 $201,913 46,953
2013-12-07 03:53 2013-12-04 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer OPT+S $34.77 20,000 $695,332 212,813
2013-12-07 03:39 2013-11-22 DXCM DEXCOM INC KAHN BARBARA Director SELL $32.63 1,500 $48,938 49,263
2013-12-06 01:14 2013-12-03 GMED GLOBUS MEDICAL INC Davidar David D Director, Officer SELL $19.25 75,000 $1,443,750 270,967
2013-12-06 02:12 2013-12-04 ECIA ENCISION INC NAUMANN-ETIENNE RUEDIGER Director BUY $0.80 5,000 $4,000 43,500
2013-12-06 02:53 2013-12-04 UTMD UTAH MEDICAL PRODUCTS INC CORNWELL KEVIN L Director, Officer SELL $51.55 1,402 $72,276 272,193
2013-12-06 03:59 2013-12-03 ARAY Accuray Incorporated DAVILA ELIZABETH H Director SELL $7.74 8,000 $61,880 77,137
2013-12-06 03:56 2013-12-04 ARAY Accuray Incorporated GOLDSTEIN JACK Director SELL $7.70 7,000 $53,921 66,237
2013-12-05 01:28 2013-11-08 BSX BOSTON SCIENTIFIC CORP Mirviss Jeffrey B. Officer OPT+S $11.91 26,000 $309,530 59,190
2013-12-05 01:12 2013-12-02 RMD RESMED INC Douglas Robert Andrew Officer OPT+S $49.10 8,000 $392,782 100,572
2013-12-05 05:19 2013-12-02 RMD RESMED INC FARRELL PETER C Director OPT+S $49.12 25,000 $1,228,075 489,876
2013-12-05 00:28 2013-12-02 PODD INSULET CORP LIAMOS CHARLES T Director, Officer OPT+S $36.26 63,808 $2,313,378 118,194
2013-12-05 00:23 2013-12-02 PODD INSULET CORP DeSisto Duane Director, Officer OPT+S $36.58 18,500 $676,819 183,933
2013-12-05 00:20 2013-12-02 PODD INSULET CORP ROBERTS BRIAN K Officer OPT+S $36.57 20,000 $731,368 99,216
2013-12-05 04:34 2013-12-03 DXCM DEXCOM INC Balo Andrew K Officer SELL $34.21 14,268 $488,158 124,297
2013-12-05 03:40 2013-12-02 DXCM DEXCOM INC GREGG TERRANCE H Director, Officer SELL $34.51 9,000 $310,590 732,889
2013-12-04 00:40 2013-12-03 ECIA ENCISION INC PACE PATRICK W Director, Officer BUY $0.80 2,000 $1,600 84,773
2013-12-03 21:22 2013-12-02 HAE HAEMONETICS CORP CONCANNON BRIAN Director, Officer OPT+S $42.31 7,600 $321,528 130,307
2013-12-03 19:39 2013-11-29 SYK STRYKER CORP STRYKER RONDA E Director SELL $74.33 21,000 $1,561,020 11,392,682
SHOW ENTRIES

Sector-Wide Insider Alpha

Analyzing insider movements across the Surgical & Medical Instruments & Apparatus sector provides a macro-view of executive conviction. When multiple leaders in different companies within the same SIC code (3841) simultaneously buy shares, it often indicates an industry-wide undervaluation or a positive shift in market cycles.

SEC Filings in Surgical & Medical Instruments & Apparatus

Every transaction in the Surgical & Medical Instruments & Apparatus industry is reported via Form 4 disclosures. By filtering these filings by industry, investors can detect institutional-scale sentiment shifts before they are reflected in broader market indices, following the capital flow of those with intimate industry knowledge.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.